Alcon Inc. (ALC)

NYSE: ALC · IEX Real-Time Price · USD
83.28
+0.65 (0.79%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Company Description

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide.

The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.

Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery.

Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers.

The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001.

Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc.
Alcon logo
Country Switzerland
Founded 1945
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 25,315
CEO David J. Endicott

Contact Details

Address:
6201 South Freeway
Fort Worth, Texas 76134
United States
Phone 817 293 0450
Website alcon.com

Stock Details

Ticker Symbol ALC
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001167379
CUSIP Number H01301128
ISIN Number CH0432492467
Employer ID 98-0205094
SIC Code 3851

Key Executives

Name Position
F. Michael Ball Executive Chairman
Arthur B. Cummings M.D. Executive Director
David J. Endicott Chief Executive Officer and Director
Timothy C. Stonesifer Chief Financial Officer
Margaret Buckley Chief Accounting Officer
Dr. Franck Leveiller Senior Vice President, Head of Global Research & Development and Chief Scientific Officer
Sue-Jean Lin Senior Vice President and Chief Information and Transformation Officer
Royce R. Bedward Senior Vice President, General Counsel and Corporate Secretary
Kimberly Martin Senior Vice President, Chief Human Resources Officer and Corporate Communications
Laurent Attias Head of Corporate Development, Strategy, BD&L and M&A

Latest SEC Filings

Date Type Title
Mar 1, 2024 144 Filing
Feb 29, 2024 144 Filing
Feb 29, 2024 144 Filing
Feb 27, 2024 6-K Report of foreign issuer
Feb 27, 2024 20-F Annual and transition report of foreign private issuers
Feb 27, 2024 6-K Report of foreign issuer
Feb 13, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Feb 1, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2023 6-K Report of foreign issuer
Aug 21, 2023 144 Filing